Centro Paulista de Investigação Clínica - CEPIC

R. Moreira e Costa, 342 - Ipiranga, São Paulo - SP, 04266-010

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Marcos Soares

Breno Balabem Alves

Natalia Ribeiro

Andrea Lomonte

Agatha Sálvio Fernandes

Tiago Freitas

Vanessa Padua

Mariana Ribeiro

Nathaly Silva

Flora Marcolino

Henrique Alves Cusin

Vitorya Jennifer Melo

Nathalia Fossaluza Gonçalves

Nathalia Martins Beiro

Giovanna Tamarindo da Silveira

Open studies

Lupus

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus - APATURA - Sanofi

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - AMETHYST - Biogen

Rare diseases

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome - POETYK SjS-1 - Bristol-Myers Squibb

Nipocalimab in Moderate to Severe Sjogren's Disease - DAFFODIL - Janssen Research & Development, LLC

Renal disease

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease - Boehringer Ingelheim

Cardiovascular disease

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Elevated Lipoprotein A

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads

Centro Paulista de Investigação Clínica - CEPIC

R. Moreira e Costa, 342 - Ipiranga, São Paulo - SP, 04266-010

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Marcos Soares

Breno Balabem Alves

Natalia Ribeiro

Andrea Lomonte

Agatha Sálvio Fernandes

Tiago Freitas

Vanessa Padua

Mariana Ribeiro

Nathaly Silva

Flora Marcolino

Henrique Alves Cusin

Vitorya Jennifer Melo

Nathalia Fossaluza Gonçalves

Nathalia Martins Beiro

Giovanna Tamarindo da Silveira

Open studies

Lupus

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus - APATURA - Sanofi

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - AMETHYST - Biogen

Rare diseases

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome - POETYK SjS-1 - Bristol-Myers Squibb

Nipocalimab in Moderate to Severe Sjogren's Disease - DAFFODIL - Janssen Research & Development, LLC

Renal disease

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease - Boehringer Ingelheim

Cardiovascular disease

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Elevated Lipoprotein A

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads